Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Mario Cazzola(Roche (Switzerland)), Carlo Brugnara(Harvard University), F. Mercuriali(Boston Children's Hospital)
Cited by 262
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
|Nature|2000|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k